VenoVision

Getting to the Heart of Hemodynamics.
A Continuous & Non-Contact Monitoring Device

Undetected Patient Deterioration

Undetected hemodynamic deterioration in patients can lead to shock, heart failure, multi-organ dysfunction and death.

This contributes to more than $200Billion of direct hospital costs on more intensive treatments, unplanned ICU admissions and extended lengths of stay from perioperative complications, as well as from related readmissions.

Non-Invasive

The system will enable the monitoring of key indicators, which previously required catheter lines to measure

AI-Driven Vision Analysis

Using proprietary analysis of thermal images, the system can provide patient vital signs that doctors know and trust

Easy to Use

In the hospital, the device will be close to the patient and be non-contact.

In the home, it will be as simple as taking a selfie

Impacting the Continuum of Care

Additional monitoring, prediction and medical alert capabilities will offer telehealth and remote monitoring services a powerful, new level of service

Leadership Team

Prof. Tal Hasin, MD

Head of Heart Failure Unit, Shaare Zedek Medical Center

Prof. Yaakov Nahmias

Director, Grass Center for Bioengineering, The Hebrew University

Jonathan Maron

MBA, The Hebrew University

The VenoVision Solution

VenoVision will help reduce all this by providing medical teams with continuous hemodynamic assessment of heart failure patients, those undergoing diuretic or fluid therapy, and general at-risk post-operative patients. Insights previously limited to cardiac catheterizations will be non-invasively captured by our easy-to-use, contactless, thermal imaging monitoring device.

By releasing the right patients earlier, monitoring more complex patients more closely, and making them all more stable, VenoVision can save the hospital up to $50k /patient.